Topiramate Treatment Is Neuroprotective and Reduces Oligodendrocyte Loss after Cervical Spinal Cord Injury

Open Access

Peer-reviewed

Research Article

John C. Gensel ,

* E-mail: gensel.1@osu.edu

Affiliation Center for Brain and Spinal Cord Repair, Department of Neuroscience, The Ohio State University College of Medicine, Columbus, Ohio, United States of America
⨯
C. Amy Tovar,

Affiliation Center for Brain and Spinal Cord Repair, Department of Neuroscience, The Ohio State University College of Medicine, Columbus, Ohio, United States of America
⨯
Jacqueline C. Bresnahan,

Affiliation Brain and Spinal Injury Center, Department of Neurological Surgery, University of California San Francisco, San Francisco, California, United States of America
⨯
Micheal S. Beattie

Affiliation Brain and Spinal Injury Center, Department of Neurological Surgery, University of California San Francisco, San Francisco, California, United States of America
⨯

Reader Comments (1)

Spinal cord injury
Is the Subject Area "Spinal cord injury" applicable to this article?

Thanks for your feedback.
Receptor antagonist therapy
Is the Subject Area "Receptor antagonist therapy" applicable to this article?

Thanks for your feedback.
Neurons
Is the Subject Area "Neurons" applicable to this article?

Thanks for your feedback.
Central nervous system
Is the Subject Area "Central nervous system" applicable to this article?

Thanks for your feedback.
Spinal cord
Is the Subject Area "Spinal cord" applicable to this article?

Thanks for your feedback.
Glutamate
Is the Subject Area "Glutamate" applicable to this article?

Thanks for your feedback.
Neuroprotectives
Is the Subject Area "Neuroprotectives" applicable to this article?

Thanks for your feedback.
Motor neurons
Is the Subject Area "Motor neurons" applicable to this article?

Thanks for your feedback.